Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board
On July 14, Prince Constantijn of the Netherlands succeeded Robbert Dijkgraaf as chairman of the Supervisory Board of Hartwig Medical Foundation.
Prince Constantijn works with a variety of organizations that aim to support and stimulate technology and innovation.
With Prince Constantijn as chairman, we expect to continue to make progress progress in the field of technology and innovation. We look forward to working together.
All news
Also read
Accreditation renewed
In October 2020, we received formal notification of the renewal of our accreditation of ISO17025: 2005 into the 2017 version. We …
In the media: Rarity – Personalised cancer treatment – fact not fiction
Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …
Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice
By Laura Nederveen In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …
Cancer is caused by DNA mutations. There are an increasing number of drugs available that act on specific errors in the DNA of an individual patient’s tumor. A drug that doesn’t fit, like a key in a lock, will not work, while the risk of side effects remains.